Back to Screener

Healthcare

Genmab A/S(GMAB)

Live Price

Offline

$26.13

+1.02% today

1Y Change

+24.77%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$16.28B
Revenue Growth
-82.7%
EPS Growth
-87.3%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Genmab A/S (GMAB) is a Healthcare stock with a market cap of $16.28B and listed on NASDAQ. The stock last traded around $26.13 and up 24.8% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -82.7%, EPS growth of -87.3%, a dividend yield of 0.0%. What stands out right now is revenue -82.7%, EPS -87.3%, free cash flow -84.8% with operating margin 36.7% and ROIC 50.3%. Valuation is more restrained than many high-expectation growth names at P/E 4.2 and price/sales 0.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GMAB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

GMAB vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

GMAB

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

GMAB Max Drawdown

-32.51%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for GMAB and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est 0.14
โ€”
โ€”
Est 924349.0B
โ€”
May 14
โ€”
Feb 17, 26
โœ—
0.05
Est 0.46
-89.1%
1058000.0B
Est 1066136.0B
-0.8%
Feb 17
โ€”
Nov 6, 25
โœ“
0.65
Est 0.48
+35.4%
1022000.0B
Est 1011055.9B
+1.1%
Nov 6
โ€”
Aug 7, 25
โœ“
0.54
Est 0.39
+38.5%
924807.3B
Est 952556.3B
-2.9%
Aug 7
โ€”
May 8, 25
โœ“
0.31
Est 0.23
+34.8%
725992.6B
Est 755467.1B
-3.9%
May 8
โ€”
Feb 12, 25
โœ“
0.57
Est 0.28
+103.6%
891434.4B
Est 791872.9B
+12.6%
Feb 12
โ€”
Nov 6, 24
โœ—
0.29
Est 0.35
-17.1%
815155.6B
Est 809619.1B
+0.7%
Nov 6
โ€”
Aug 8, 24
โœ—
0.22
Est 0.29
-24.1%
777834.0B
Est 679426.2B
+14.5%
Aug 8
โ€”
May 2, 24
โ€”
0.16
Est 0.16
0.0%
594934.8B
Est 530810.2B
+12.1%
May 2
โ€”
Feb 14, 24
โœ“
0.36
Est 0.34
+5.9%
690325.8B
Est 671209.8B
+2.9%
Feb 14
โ€”
Nov 7, 23
โœ—
0.47
Est 3.14
-85.0%
669378.4B
Est 642855.4B
+4.1%
Nov 7
โ€”
Aug 3, 23
โœ—
0.30
Est 2.18
-86.2%
613292.8B
Est 601126.2B
+2.0%
Aug 3
โ€”
May 10, 23
โœ—
0.05
Est 0.65
-92.3%
416079.9B
Est 404256.4B
+2.9%
May 10
โ€”
Feb 22, 23
โœ—
0.12
Est 3.15
-96.2%
754972.9B
Est 681422.2B
+10.8%
Feb 22
โ€”
Nov 9, 22
โœ—
0.53
Est 1.65
-67.9%
535642.2B
Est 473493.2B
+13.1%
Nov 9
โ€”
Aug 10, 22
โœ—
0.41
Est 1.55
-73.5%
443981.7B
Est 412042.0B
+7.8%
Aug 10
โ€”
May 11, 22
โœ—
0.11
Est 0.91
-87.9%
315144.7B
Est 300486.3B
+4.9%
May 11
โ€”
Feb 16, 22
โœ—
0.17
Est 5.30
-96.8%
399161.8B
Est 389001.1B
+2.6%
Feb 16
โ€”
Nov 10, 21
โœ“
0.21
Est 0.11
+90.9%
360406.2B
Est 270347.6B
+33.3%
Nov 10
โ€”
Aug 11, 21
โ€”
0.08
Est 0.08
0.0%
314356.5B
Est 353273.1B
-11.0%
Aug 11
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener